Vivaldi Asset Management »

Drugs Made In Amer Acqutn shares owned by Vivaldi Asset Management

Quarter-by-quarter ownership of Drugs Made In Amer Acqutn (DMAA) shares owned by Vivaldi Asset Management from 13F filings

Historical chart of Vivaldi Asset Management investment in Drugs Made In Amer Acqutn

Tip: Access up to 7 years of quarterly data

All positions including Drugs Made In Amer Acqutn held by Vivaldi Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Drugs Made In Amer Acqutn by Vivaldi Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $23M 2.2M 10.27
2025-06-30 $23M 2.2M 10.20
2025-03-31 $21M 2.1M 10.02

More positions owned by Vivaldi Asset Management

WNS HLDGS Equity (WNS)
Verona Pharma Equity (VRNA)
Veritex Hldgs Equity (VBTX)
Mr Cooper Group Equity
Cyberark Software Equity (CYBR)
Electronic Arts Equity (EA)
Aris Water Solutions Equity (ARIS)
Kellanova Equity (K)
Agriculture & Nat Sol Acq Equity (ANSC)
Tourmaline Bio Equity (TRML)
Avidxchange Holdings Equity (AVDX)
Aa Mission Acquisition Corp Equity (AAM)
Centurion Acquisition Corp Equity (ALF)
Merus N V Equity (MRUS)
Drugs Made In Amer Acqutn Equity (DMAA)

View all positions for Vivaldi Asset Management

Top funds holding Drugs Made In Amer Acqutn

Karpus Investment Management
Vivaldi Asset Management
Polar Securities
Glazer Capital
Westchester Capital Management
Hudson Bay Capital Management
Wolverine Asset Management
Mizuho Securities Usa
Aristeia Capital
D. E. Shaw & Co
Heights Capital Management
Radcliffe Capital Management
LMR Partners
Boothbay Fund Management
Atw Spac Management

View all funds holding Drugs Made In Amer Acqutn